NYC-based Proxima, which uses AI to design drugs that control protein interactions, raised an $80M seed led by DCVC, with participation from Nvidia and others (Agnee Ghosh/Bloomberg)

Agnee Ghosh / Bloomberg:
NYC-based Proxima, which uses AI to design drugs that control protein interactions, raised an $80M seed led by DCVC, with participation from Nvidia and others  —  Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 million in seed funding …